Mark T Iwicki - Net Worth and Insider Trading
Mark T Iwicki Net Worth
The estimated net worth of Mark T Iwicki is at least $3 Million dollars as of 2024-12-26. Mark T Iwicki is the CHIEF EXECUTIVE OFFICER of Kala Bio Inc and owns about 263,755 shares of Kala Bio Inc (KALA) stock worth over $2 Million. Mark T Iwicki is also the Director of Aimmune Therapeutics Inc and owns about 29,375 shares of Aimmune Therapeutics Inc (AIMT) stock worth over $1 Million. Details can be seen in Mark T Iwicki's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark T Iwicki has not made any transactions after 2024-06-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark T Iwicki
Mark T Iwicki Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark T Iwicki owns 7 companies in total, including Aimmune Therapeutics Inc (AIMT) , Merus NV (MRUS) , and Kala Bio Inc (KALA) among others .
Click here to see the complete history of Mark T Iwicki’s form 4 insider trades.
Insider Ownership Summary of Mark T Iwicki
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AIMT | Aimmune Therapeutics Inc | 2020-10-10 | director |
| MRUS | Merus NV | 2021-05-28 | director |
| KALA | Kala Bio Inc | 2024-06-26 | director & Chief Executive Officer |
 | | 2022-06-02 | director |
| | 2015-12-08 | director |
| | 2021-06-29 | director |
| | 2022-09-14 | director |
Mark T Iwicki Latest Holdings Summary
Mark T Iwicki currently owns a total of 2 stocks. Among these stocks, Mark T Iwicki owns 263,755 shares of Kala Bio Inc (KALA) as of June 26, 2024, with a value of $2 Million and a weighting of 62.23%. Mark T Iwicki also owns 29,375 shares of Aimmune Therapeutics Inc (AIMT) as of February 26, 2018, with a value of $1 Million and a weighting of 37.77%.
Latest Holdings of Mark T Iwicki
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KALA | Kala Bio Inc | 2024-06-26 | 263,755 | 6.33 | 1,669,569 |
| AIMT | Aimmune Therapeutics Inc | 2018-02-26 | 29,375 | 34.49 | 1,013,144 |
Holding Weightings of Mark T Iwicki
Mark T Iwicki Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark T Iwicki has made a total of 9 transactions in Kala Bio Inc (KALA) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Kala Bio Inc is the sale of 15,168 shares on June 26, 2024, which brought Mark T Iwicki around $72,048.
According to the SEC Form 4 filings, Mark T Iwicki has made a total of 0 transactions in Aimmune Therapeutics Inc (AIMT) over the past 5 years. The most-recent trade in Aimmune Therapeutics Inc is the acquisition of 9,375 shares on February 26, 2018, which cost Mark T Iwicki around $300,000.
Insider Trading History of Mark T Iwicki
- 1
Mark T Iwicki Trading Performance
GuruFocus tracks the stock performance after each of Mark T Iwicki's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark T Iwicki is -7.63%. GuruFocus also compares Mark T Iwicki's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark T Iwicki within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark T Iwicki's insider trading performs compared to the benchmark.
Performance of Mark T Iwicki
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.26 | | | | | |
| Relative Return to S&P 500(%) | 11.38 | | | | | |
Mark T Iwicki Ownership Network
Mark T Iwicki Owned Company Details
What does Aimmune Therapeutics Inc do?
Who are the key executives at Aimmune Therapeutics Inc?
Mark T Iwicki is the director of Aimmune Therapeutics Inc. Other key executives at Aimmune Therapeutics Inc include 10 percent owner Societe Des Produits Nestle S.a. , Chief Financial Officer Eric Bjerkholt , and Chief Medical Officer Adelman Daniel C Md .
Aimmune Therapeutics Inc (AIMT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aimmune Therapeutics Inc (AIMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aimmune Therapeutics Inc (AIMT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aimmune Therapeutics Inc (AIMT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aimmune Therapeutics Inc Insider Transactions
Mark T Iwicki Mailing Address
Above is the net worth, insider trading, and ownership report for Mark T Iwicki. You might contact Mark T Iwicki via mailing address: 84 Waterford Drive, Marlborough Ma 01752.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
